INTRODUCTION
I n the past decade, the IndustrIalIzatIon of compound management processes to support drug discovery has matured. 1,2 compound collections have grown from hundreds of thousands to millions of compounds, and the compound management infrastructure has had to evolve to handle large sample sets in a timely manner. synergies between compound management and high-throughput screening (hts) groups had resulted in efficiencies in primary screening through miniaturization that have maintained timelines, contained costs, and minimized the depletion of compounds. 3, 4 although multiple chemotypes can usually be identified using hts, transforming the hits into leads has become a bottleneck for drug discovery. typically, initial screening hits are complemented by additional compound collection searches and computational mining, after which selected chemotypes are selected for optimization. historically, this part of the discovery process has been undertaken by therapeutic area (ta)based teams. ta biologists provided in vitro data to medicinal chemistry teams to optimize target selectivity and potency. however, as the number of targets and assays has increased, there has been a concomitant demand to contain costs and minimize compound consumption. one potential solution is to introduce miniaturized assays, but this comes at a cost as the assay platforms, and support infrastructure would need to be replicated for each ta.
an alternative scenario is to centralize the in vitro testing process and directly integrate compound management into the process. this approach has been taken by a number of companies and is proving to be a useful way of streamlining the discovery process and controlling costs. 5 another significant trend in lead optimization is the integration of data from absorption, drug metabolism, drug-drug interaction, and in vitro toxicology. again, using a centralization paradigm, compound management can be directly integrated such that 1 vial of compound can be used to provide structure activity, selectivity, and structure liability data. to address this challenge, the focus for compound management groups has evolved from simple support of hts to include additional processes further downstream in the drug discovery process. a number of organizations have undertaken initiatives to integrate information technology (It) and compound management support into a centralized platform that can be accessed to prosecute lead optimization samples in a holistic manner. 6 commonalities of practice for compound handling through the use of automation have improved the data quality as more consistent and uniform data sets were achieved. 7, 8 Intertwined in this process are informatics, automation, and compound management platforms that continue to evolve to facilitate rapid data-driven decision making while conserving compound stocks and overall costs.
to streamline the lead optimization process, organizations need to address process inefficiencies in the entire workflow from sample synthesis through testing to final data analysis. lean six sigma methodologies focus on removing non-value-adding work from processes, improving efficiencies and quality and minimizing costs. 9 When applying this methodology, organizations can make informed decisions on what areas need improvement and where capacity constraints are occurring. We describe an approach taken to make the lead optimization process leaner by implementing a method in which rapid retrieval of samples via local storage, effectively routing samples to assays, and workflow enhancements in compound management processes are achieved through informatics and automated platforms.
APPLYING SIx SIGMA METHODOLOGY TO IMPROVE COMPOUND MANAGEMENT PROCESSES
the six sigma methodology, used to improve existing processes of a business, consists of 5 steps: define, measure, analyze, improve, and control (dmaIc). 10 We have previously described our use of these lean manufacturing concepts to improve rapid analog library synthesis. 11 through the use of these 5 steps, we streamlined workflows affecting productivity and capacity on both the human and instrumentation levels. understanding the needs of the chemists and biologists, how these needs fit into an overall strategy, and where process improvements need to occur is vital for groups defining areas for improvement. In cases where multiple program compounds are being screened through multiple assays, maintaining turnaround times and instrumentation capacity for assay plate creation can be challenging. When capacity constraints exist in compound management, biology groups cannot effectively use their instrumentation capacity to assay compounds. conversely, too many samples can introduce bottlenecks for biologists as instrumentation and the supply of reagents might not meet the demand. the key is to balance capacity across the workflow so that the normal ebbs and flows from compound submission to assay testing can be managed.
It is important to understand the overall process to recognize where bottlenecks and potential delays can occur. measuring distractions and interactions that occur in a process can identify areas for optimization ( Fig. 1) . critical factors affecting productivity need to be analyzed to determine where full-time equivalent (fte) and instrumentation utilization can be optimized. for compound management, developing a bandwidth analysis is a very effective tool to identify and measure where critical factors are present in a process. Breaking down each step in the current workflow and equating time for each task highlights how much instrument and fte time is being used in a process. In addition, implementing standard operating procedures (sops) and visual process controls to eliminate errors helps improve the quality of the process.
the lead optimization process was initially piloted for 5 to 10 programs at a single site. for the small number of programs, existing software tools and automation were sufficient to drive these programs forward at accelerated rates. as the lead optimization model became successful, more programs adopted this approach, and issues of maintaining timelines began to surface. It became extremely difficult to scale this model to provide support for 25 programs per site. to alleviate this problem, we undertook a lean sigma approach. the dmaIc methodology was applied to compound processing for lead optimization, and a project charter was developed where the problem was identified. the goal was to ascertain the root cause of delay in timelines and an inability to maintain service-level agreements with our customers. out of this analysis, we hoped to provide alternative solutions to be able to support a scalable model for programs at multiple sites. efficiency experts polled chemistry, biology, and compound management groups via interviews to determine and collate the needs of each group or the "voice of the customer." next, a process map generation was used as a tool for chemistry, biology, and compound management groups to determine where bottlenecks and manual processes were taking place from sample synthesis to assay analysis.
data were generated using a capacity analysis model by assigning timings to each task. upon analysis, it was determined that instrumentation was not the bottleneck; rather, it was fte utilization. too much time was spent on manual tasks to funnel samples into the appropriate program workflows. In addition, physical location of program samples was also identified as a bottleneck due to time involved for offsite shipments. In essence, 3 major areas were identified in which processing could be streamlined: (a) storing of samples locally, (b) routing of samples into assays, and (c) software to optimize plating processes.
IMPLEMENTATION OF LOCAL STORAGE
compound management organizations manage and store compounds based on factors such as the number of sites being supported and whether a centralized or distributed model is used (Fig. 2) . In the centralized approach, historical and newly created samples are stored in a central repository for distribution. for organizations consisting of a single site, distributing samples from the central archive is a very efficient process due to the close proximity of the sample archive and the end user. samples can be readily and quickly ordered and accessed for the desired assays.
When organizations with multiple sites employ the centralized approach, samples are stored in a central archive and shipped to "remote" sites for testing. timeframes in which samples are screened at remote sites can be problematic when factoring in order size and shipping times from the central archive. for samples synthesized at remote sites, 48 hours was added to the lead optimization cycle time to ship and inventory samples at the central archive. In addition, another 72 hours was added to the cycle time to ship the samples back to the origination site in the desired format for receipt and processing. sequential testing of a sample through multiple assays, in different laboratories, can further acerbate the delay and increase compound consumption. In addition, chemists and biologists residing at remote sites are frequently unable to readily access program compounds locally for in vivo/in vitro testing, causing even further delays in decision making.
several compound management organizations have therefore implemented a distributed approach that supports shortterm storage of samples locally for testing in assays ( Fig. 3) . 12 Implementation of local sample repositories in compound management provided convenient access for chemists and biologists to screen compounds of interest. commonalities of practice were implemented through the compound management organization for storing samples to ensure consistency in sample handling. process standardizations were implemented across all sites via software to maintain inventory and manage work order fulfillment. With the elimination of intersite shipping, screening cycle times were reduced from an average of 5 days to a matter of hours (80%-90% gain in efficiency). With local storage implemented, efforts were focused on streamlining the routing of compounds into lead optimization workflows.
ROUTING COMPOUNDS
In the past, samples synthesized for a program or requested from the archive were tested sequentially from primary screening through secondary assays. handling of compounds in different laboratories using diverse technologies occasionally led to variability in assay data. consequently, data interpretation was delayed and decision making was hindered. In addition, although compound request systems worked well in routing samples to individual biologists for screening, they were not capable of effectively routing samples simultaneously to multiple assays in multiple labs. the lack of It infrastructure resulted in the manual processing of compounds to overcome this limitation. e-mail chains and paper trails resulting from ad hoc workflows contributed to inefficiencies in data generation.
to alleviate these issues, we implemented a new paradigm to test compounds simultaneously across multiple assays. compound management partnered with It and biology groups to improve processes by reducing workflow variability and increasing the speed at which request and submissions were received and processed. handling of compounds via a common mechanism provided a means to reduce variability and improved efficiency. synthesis of a new compound routed it automatically through a variety of biological tests so that a dossier of information would be generated and provided for chemistry and biology teams. Quicker turnaround times for delivery of assay-ready plates to biology groups were achieved as a new assay request system provided the ability to order compounds from either local or central inventories. shifting to this paradigm efficiently routed compounds through the lead optimization workflow described in Figure 4 .
as a result of these changes, a number of improvements became apparent. for instance, when samples had to be retested for an assay, compound management personnel were spending many hours per week due to lack of a formal request system. upon implementation of the assay request system and enhanced applications, the time needed for processing retest requests was reduced to an hour per week, resulting in 89% efficiency gain. although these solutions work well for the relatively small number of samples that pass through the lead optimization process, other solutions are more amenable to the large sample sets used in hit identification.
In another example, creation of a centralized model to standardize the routing of samples enabled chemists and biologists to predetermine the amount of compound needed to test against a specific set of assays. a single vial containing this predetermined quantity of compound was then used to simultaneously generate multiple sets of assay-ready plates. Biological data were now generated in parallel and decisions made quickly. commonality of practice in compound handling through automation also improved data quality in biological assays due to consistently higher degrees of accuracy and precision.
SOFTWARE TO OPTIMIZE PLATING PROCESSES
compound management used It and automation tools to facilitate sample handling and the associated data through lead optimization processes. Integration of various applications to funnel samples effectively through plating workflows was required. compound inputs originate from various physical locations in a variety of container types (microtubes, plates, vials). prior to the lean six sigma improvements, each source container type required separate plating operations to create a plate. therefore, if input compounds were stored in microtubes, plates, and vials, 3 separate plating operations had to be performed. manual reformatting and multiple plating orders were necessary to move compounds through the plating workflow. this was clearly an inefficient process that was being restricted by inappropriate integration of It and automation. as a result, liquid-handling operations became lengthy, and time spent on processing multiple plating orders increased.
to address these inefficiencies, we initiated It support with a goal to remove manual and redundant tasks from a plating workflow. task-driven spreadsheets were developed to track timings associated to handling multiple plating orders. results were used as a foundation to determine where efficiencies could be improved through the use of informatics to rebuild the process. enhanced applications were developed to consolidate various container types into a singular plating order to streamline the plating process. pre-and post-timings were captured and compared to determine what efficiencies were gained. results showed the average number of plating orders decreased from 104 to 79 or by 31% per month.
In another example, we looked to balance the constraints between standardization of plating workflows with limited flexibility versus providing extremely flexible workflows for assay biologists. plate formats dictate the location of samples in a plate and drive the plating processes in compound management. although providing flexibility in plating workflows accommodates an individual biologist's needs, it reduces efficiency in the plate creation process as more variability and complexity are introduced. When the overall number of plate formats supported for plate creation increases, downstream plating processes require automation and It to accommodate all possible combinations. as illustrated in Figure 5 , the nonoptimized plating workflows supporting multiple formats can create a large number of potential plating combinations for compound management staff to manage. distribution to multiple customers in unique plate formats created inefficiencies for automated liquid-handling instrumentation. In addition, administrative overhead to validate each variation in a plating workflow was manually intensive.
to address this issue, we standardized plate formats to bring efficiency into the plating process while maintaining some degree of flexibility. In working with biology and automation groups, plate formats were collated across multiple sites for each assay platform to determine where standardization could take place. previously, 20 unique formats for lead optimization processes were supported, which resulted in approximately 700 possible combinations. using the more optimized approach reduced the number of possible combinations to 3, thus providing a more sustainable model for plating compounds. In some instances, this has increased the number of samples that could be processed by 35% because the processing time for assay plate creation was reduced from 8.5 to 5.5 h. Business rules and sops were also implemented as a process control measure to ensure standardization.
addressing downstream bottlenecks in a plating workflow that impede the speed in assay plate creation was also investigated. time-consuming plating processes such as serial dilutions led to capacity constraints on liquid-handling equipment. sequential plating operations in which plates are batched through liquid-handling operations also resulted in work sitting idle as workflows could not complete until all plates were processed. In this case, replication processes could not start until all serial dilutions were completed and the associated data generated for further downstream processing. to enable a continuous flow of samples, we enhanced automated systems and the software to use parallel processing for serial dilution and replication tasks (Fig. 6) . as seen in Figure 6 , there is a gain of 10 mins for every master plate created using the parallel process, resulting in better instrumentation utilization and throughput for assay plate creation. 
CONCLUSION
adopting a continuous improvement approach and lean six sigma methodologies in compound management departments can increase productivity and efficiencies, thereby driving down costs in supporting lead optimization workflows. forming tight collaborations with informatics, chemistry, and biology groups to provide synergies in the overall lead optimization workflow can shorten timelines in which compounds get screened. delivering It and automation enhancements to augment compound management process capabilities can streamline workflows and increase bandwidth for processing samples through lead optimization processes. although process and plate format standardizations were achievable and implemented across all sites for lead optimization workflows in this lean six sigma project, these standardizations did not carry over to hit identification. this is due to different process and plating requirements. In the case of lead optimization, a single sample is routed through multiple assays, whereas in hit identification, many compounds go through the same assay. In addition, hit identification processes have matured over the years and have already been streamlined.
reducing non-value-adding work from processes through continuous workflows can improve instrumentation efficiency and reduce overall fte utilization. Implementation of local storage with process standardizations to control and effectively route samples to desired assays can improve cycle times for screening of compounds. chemistry groups can make quicker decisions in moving programs forward as the dossier of data provided for compounds is more readily available.
